Your browser doesn't support javascript.
loading
The Impact of Pulmonary Vascular Obstruction on the Risk of Recurrence of Pulmonary Embolism: A French Prospective Cohort.
Orione, Charles; Tromeur, Cécile; Le Mao, Raphael; Le Floch, Pierre-Yves; Robin, Philippe; Hoffmann, Clément; Bressollette, Luc; Nonent, Michel; Le Roux, Pierre-Yves; Salaun, Pierre-Yves; Guegan, Marie; Poulhazan, Elise; Lacut, Karine; Leroyer, Christophe; Lemarié, Catherine A; Couturaud, Francis.
Afiliação
  • Orione C; Département de Médecine Interne et Pneumologie, Centre Hospitalo-Universitaire de Brest, Université de Bretagne Occidentale, CIC INSERM, FCRIN INNOVTE, Brest, France.
  • Tromeur C; Département de Médecine Interne et Pneumologie, Centre Hospitalo-Universitaire de Brest, Université de Bretagne Occidentale, CIC INSERM, FCRIN INNOVTE, Brest, France.
  • Le Mao R; Département de Médecine Interne et Pneumologie, Centre Hospitalo-Universitaire de Brest, Université de Bretagne Occidentale, CIC INSERM, FCRIN INNOVTE, Brest, France.
  • Le Floch PY; Service de radiologie, Centre Hospitalo-Universitaire de Brest, Université de Bretagne Occidentale, CIC INSERM 1412, FCRIN INNOVTE, Brest, France.
  • Robin P; Service de Médecine Nucléaire, Centre Hospitalo-Universitaire de Brest, Université de Bretagne Occidentale, GIRC Thrombose, Brest, France.
  • Hoffmann C; Service d'Echo-doppler Vasculaire, Centre Hospitalo-Universitaire de Brest, Université de Bretagne Occidentale, CIC INSERM 1412, FCRIN INNOVTE, Brest, France.
  • Bressollette L; Service d'Echo-doppler Vasculaire, Centre Hospitalo-Universitaire de Brest, Université de Bretagne Occidentale, CIC INSERM 1412, FCRIN INNOVTE, Brest, France.
  • Nonent M; Service de radiologie, Centre Hospitalo-Universitaire de Brest, Université de Bretagne Occidentale, CIC INSERM 1412, FCRIN INNOVTE, Brest, France.
  • Le Roux PY; Service de Médecine Nucléaire, Centre Hospitalo-Universitaire de Brest, Université de Bretagne Occidentale, GIRC Thrombose, Brest, France.
  • Salaun PY; Service de Médecine Nucléaire, Centre Hospitalo-Universitaire de Brest, Université de Bretagne Occidentale, GIRC Thrombose, Brest, France.
  • Guegan M; Département de Médecine Interne et Pneumologie, Centre Hospitalo-Universitaire de Brest, Université de Bretagne Occidentale, CIC INSERM, FCRIN INNOVTE, Brest, France.
  • Poulhazan E; Centre Hospitalo-Universitaire de Brest, Université de Bretagne Occidentale, CIC INSERM 1412, FCRIN INNOVTE, Brest, France.
  • Lacut K; Centre Hospitalo-Universitaire de Brest, Université de Bretagne Occidentale, CIC INSERM 1412, FCRIN INNOVTE, Brest, France.
  • Leroyer C; Département de Médecine Interne et Pneumologie, Centre Hospitalo-Universitaire de Brest, Université de Bretagne Occidentale, CIC INSERM, FCRIN INNOVTE, Brest, France.
  • Lemarié CA; Département de Médecine Interne et Pneumologie, Centre Hospitalo-Universitaire de Brest, Université de Bretagne Occidentale, CIC INSERM, FCRIN INNOVTE, Brest, France.
  • Couturaud F; Département de Médecine Interne et Pneumologie, Centre Hospitalo-Universitaire de Brest, Université de Bretagne Occidentale, CIC INSERM, FCRIN INNOVTE, Brest, France.
Thromb Haemost ; 121(7): 955-963, 2021 Jul.
Article em En | MEDLINE | ID: mdl-33469906
ABSTRACT

BACKGROUND:

We aimed to assess whether high pulmonary vascular obstruction index (PVOI) measured at the time of pulmonary embolism (PE) diagnosis is associated with an increased risk of recurrent venous thromboembolism (VTE). STUDY DESIGN AND

METHODS:

French prospective cohort of patients with a symptomatic episode of PE diagnosed with spiral computerized tomography pulmonary angiography (CTPA) or ventilation-perfusion (V/Q) lung scan and a follow-up of at least 6 months after anticoagulation discontinuation. PVOI was assessed based on the available diagnostic exam (V/Q lung scan or CTPA). All patients had standardized follow-up and independent clinicians adjudicated all deaths and recurrent VTE events. Main outcome was recurrent VTE after stopping anticoagulation.

RESULTS:

A total of 418 patients with PE were included. During a median follow-up period of 3.6 (1.2-6.0) years, 109 recurrences occurred. In multivariate analysis, PVOI ≥ 40% was an independent risk factor for recurrence (hazard ratio 1.77, 95% confidence interval 1.20-2.62, p < 0.01), whether PE was provoked by a major transient risk factor or not. A threshold at 41% was identified as the best value associated with the risk of recurrence 6 months after stopping anticoagulation (area under curve = 0.64).

CONCLUSION:

PVOI ≥ 40% at PE diagnosis was an independent risk factor for recurrence VTE. Further prospective validation studies are needed.
Assuntos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Embolia Pulmonar / Tromboembolia Venosa / Anticoagulantes Tipo de estudo: Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Adult / Aged / Female / Humans / Male / Middle aged País/Região como assunto: Europa Idioma: En Revista: Thromb Haemost Ano de publicação: 2021 Tipo de documento: Article País de afiliação: França

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Embolia Pulmonar / Tromboembolia Venosa / Anticoagulantes Tipo de estudo: Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Adult / Aged / Female / Humans / Male / Middle aged País/Região como assunto: Europa Idioma: En Revista: Thromb Haemost Ano de publicação: 2021 Tipo de documento: Article País de afiliação: França